English (PDF) – 2 Pages 290kb
Singapore The Business Times, Growing business opportunities (page 6) English (PDF) – 15 Pages 8799kb
London/Cambridge and Zurich: A comparison in numbers, London English (PDF) – 14 Pages 648kb
Most companies dream about closing a licensing deal with big Pharma. But what do these deals really contain from a financial perspective and can any trends be found for potential big Pharma licensees in order to assist licensors in the deal making process? To gain insight in these aspects, we have analyzed the financial deal … Continue reading How big Pharma companies structure their licensing deals – prepare for BIO 2012
Amsterdam March 2012: An overview of the state of the Biotech Industry was given by BIOs Industry Research & Analyst David Thomas at BIOEuropeSpring in Amsterdam. He made three main points: Public market have gained 25% in the last couple of month Private Biotechs still have a hard time to find investors Partnering and deal making … Continue reading Public Biotechs – Light at the end of the tunnel, although private Biotechs may have to wait a bit longer
Interviews with leading Life Sciences companies: Interprotein Corporation English (PDF) – 3 pages – 680kb
Partnering and Investment – is the VC, Pharma, Biotech eco-system dead? English (PDF) – 5 pages – 264kb
Interviews with leading Life Sciences companies: AVA-CO2 Schweiz AG English (PDF) – 4 pages – 1001kb